Results 271 to 279 of about 98,022 (279)

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase

Journal of Cerebral Blood Flow and Metabolism, 1997
Matthias Endres, Zhao-Qi Wang, Christian Waeber   +2 more
exaly  

Poly(ADP-ribose) (PAR) polymer is a death signal

Proceedings of the National Academy of Sciences of the United States of America, 2006
Shaida A Andrabi, Seong-Woon Yu, Hongmin Wang   +2 more
exaly  

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Lancet Oncology, The, 2013
Victor Moreno, Susana Miranda, Johann Sebastian de Bono   +2 more
exaly  

Role Poly(ADP-Ribose)Polymerase-1 in Neurologic Disorders

2002
Marc F.Poitras, Ted M.Dawson, Valina L.Dawson   +2 more
openaire   +1 more source

Role of poly(ADP-ribose) formation in DNA repair

Nature, 1992
exaly  

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
Jianqing Zhu, Mo Chen, Ning Li
exaly  

(ADP-ribose)n participates in DNA excision repair

Nature, 1980
exaly  

Poly(ADP-ribose) levels in carcinogen-treated cells

Nature, 1979
exaly